Form 4: AEON Biopharma Executive Buys Shares
Insider Transaction (Form 4)
Jennifer Sy, Chief Accounting Officer of AEON Biopharma, Inc., purchased 153,846 shares of common stock on November 19, 2026 for $0.13 per share.
Summary
- Open-market purchase: acquired 153,846 Class A Common Stock at $0.13 ($19,985) on November 19, 2026; holds 1,655,022 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $19,985, committing personal capital to the stock.
Insider Transactions
Jennifer Sy — Officer (Chief Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-19 | Open-market purchase | Class A Common Stock | 153,846 | $0 | $20.0K | 1,655,022 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-19 | Open-market purchase (153,846 shares) |
Keywords
insider transaction, Form 4, AEON, AEON Biopharma, Inc., bullish, Jennifer Sy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.